BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

15 related articles for article (PubMed ID: 38466402)

  • 1. Long-term outcomes of critically ill patients with hematological malignancies: what is the impact of the coronavirus disease 2019 pandemic?
    Oud L
    Intensive Care Med; 2024 May; ():. PubMed ID: 38805042
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of Days Alive and at Home at Day 90 After Intensive Care Unit Admission With Long-term Survival and Functional Status Among Mechanically Ventilated Patients.
    Taran S; Coiffard B; Huszti E; Li Q; Chu L; Thomas C; Burns S; Robles P; Herridge MS; Goligher EC
    JAMA Netw Open; 2023 Mar; 6(3):e233265. PubMed ID: 36929399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in critically ill patients with hematological malignancy admitted to the general intensive care unit: a single-center experience in Japan.
    Irie H; Otake T; Kawai K; Hino M; Namazu A; Shinjo Y; Yamashita S
    J Anesth; 2017 Oct; 31(5):736-743. PubMed ID: 28766020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contribution of frailty, cognition, activity of daily life and comorbidities on outcome in acutely admitted patients over 80 years in European ICUs: the VIP2 study.
    Guidet B; de Lange DW; Boumendil A; Leaver S; Watson X; Boulanger C; Szczeklik W; Artigas A; Morandi A; Andersen F; Zafeiridis T; Jung C; Moreno R; Walther S; Oeyen S; Schefold JC; Cecconi M; Marsh B; Joannidis M; Nalapko Y; Elhadi M; Fjølner J; Flaatten H;
    Intensive Care Med; 2020 Jan; 46(1):57-69. PubMed ID: 31784798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium--a groupe de recherche respiratoire en réanimation onco-hématologique study.
    Azoulay E; Mokart D; Pène F; Lambert J; Kouatchet A; Mayaux J; Vincent F; Nyunga M; Bruneel F; Laisne LM; Rabbat A; Lebert C; Perez P; Chaize M; Renault A; Meert AP; Benoit D; Hamidfar R; Jourdain M; Darmon M; Schlemmer B; Chevret S; Lemiale V
    J Clin Oncol; 2013 Aug; 31(22):2810-8. PubMed ID: 23752112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Poor Outcomes in Critically Ill Adults with Hematologic Malignancy.
    Cornish M; Butler MB; Green RS
    Can Respir J; 2016; 2016():9431385. PubMed ID: 27445571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival and functional outcomes of critically ill patients with hematologic malignancies: a Canadian multicenter prospective study.
    Munshi L; Dumas G; Rochwerg B; Shoukat F; Detsky M; Fergusson DA; Ferreyro BL; Heffernan P; Herridge M; Magder S; Minden M; Patel R; Qureshi S; Schimmer A; Thyagu S; Wang HT; Mehta S
    Intensive Care Med; 2024 Apr; 50(4):561-572. PubMed ID: 38466402
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.